Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Impedimed Limited ( (AU:IPD) ) is now available.
Impedimed Limited announced the cessation of certain securities, specifically the lapse of 1,181,000 options and 7,556,058 performance rights due to unmet conditions. This announcement may impact the company’s financial structure and could influence investor perceptions regarding the company’s operational and strategic execution.
The most recent analyst rating on (AU:IPD) stock is a Buy with a A$0.07 price target. To see the full list of analyst forecasts on Impedimed Limited stock, see the AU:IPD Stock Forecast page.
More about Impedimed Limited
Impedimed Limited operates in the medical technology industry, focusing on developing and providing innovative non-invasive medical devices. The company’s primary products are designed to measure, monitor, and manage fluid status and body composition, with a particular emphasis on applications in healthcare settings.
YTD Price Performance: -5.77%
Average Trading Volume: 2,138,458
Technical Sentiment Signal: Sell
Current Market Cap: A$99.77M
For a thorough assessment of IPD stock, go to TipRanks’ Stock Analysis page.